Maitalon

Drospirenone/Ethinylestradiol, the active ingredients in Maitalon, are a combined oral contraceptive presented as a tablet for oral use. It provides contraception and helps regulate menstrual cycles in women of reproductive age.

GNH USA supplies Maitalon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Maitalon, a combined oral contraceptive, is used to manage reproductive health by influencing hormonal pathways.

- Contraception: prevents pregnancy by suppressing ovulation and altering cervical mucus. - Menstrual cycle regulation: promotes more predictable bleeding patterns and reduces menstrual discomfort.

Maitalon may cause a range of adverse reactions. The most frequently reported events are generally mild and transient.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Breast tenderness: discomfort or swelling of the breasts. - Headache: occasional tension‑type headache. - Spotting: irregular bleeding between periods.

Serious or Rare Side Effects: - Blood clots: deep‑vein thrombosis, pulmonary embolism, or arterial thrombosis. - Severe hypertension: sudden increase in blood pressure. - Liver dysfunction: abnormal liver enzymes or jaundice.

Before prescribing Maitalon, clinicians should evaluate individual risk factors and counsel patients on safe use.

- Assess thrombotic risk: review personal and family history of clotting disorders. - Screen for cardiovascular disease: avoid in patients with uncontrolled hypertension or coronary artery disease. - Evaluate liver function: contraindicated in active liver disease. - Counsel on smoking: smoking increases thrombotic risk, especially in women over 35. - Review medication list: certain drugs can reduce contraceptive efficacy. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and light.

Maitalon can interact with several medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): may markedly reduce hormone levels. - Rifampin and other strong antibiotics: can diminish contraceptive efficacy. - Protease inhibitors (e.g., ritonavir): may increase hormone concentrations. - St. John's wort: herbal inducer that lowers contraceptive effectiveness.

Moderate Interactions (Monitor Closely): - Antifungals such as ketoconazole: may raise hormone levels, requiring monitoring. - Selective serotonin reuptake inhibitors (SSRIs): can increase bleeding tendency. - Diuretics: may affect fluid balance and blood pressure, warranting observation.